Capital Fund Management S.A. Abbott Laboratories Call Options Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $2.24 Million - $2.65 Million	-22,400 Reduced 22.38%	77,700 $8.86 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $18.7 Million - $20.9 Million	-186,100 Reduced 65.02%	100,100 $10.4 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $11.4 Million - $12.6 Million	104,500 Added 57.51%	286,200 $32.5 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $40.6 Million - $49.7 Million	-450,200 Reduced 71.25%	181,700 $20 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $30.2 Million - $36.3 Million	316,400 Added 100.29%	631,900 $61.2 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $26.7 Million - $29.7 Million	-264,800 Reduced 45.63%	315,500 $34.4 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $24.8 Million - $29.2 Million	255,700 Added 78.77%	580,300 $58.8 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $5.51 Million - $6.47 Million	58,000 Added 21.76%	324,600 $35.6 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $25.8 Million - $29.9 Million	266,600 New	266,600 $25.8 Billion
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $12 Million - $14.6 Million	-105,200 Reduced 91.16%	10,200 $1.21 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $1.92 Million - $2.35 Million	16,600 Added 16.8%	115,400 $16.2 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $338,528 - $398,496	3,200 Added 3.35%	98,800 $11.5 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $6.47 Million - $7.62 Million	59,400 Added 164.09%	95,600 $11.5 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $2.02 Million - $2.45 Million	22,000 Added 154.93%	36,200 $3.94 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $892,056 - $967,266	-10,900 Reduced 43.43%	14,200 $1.19 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $189,488 - $221,000	-2,600 Reduced 9.39%	25,100 $2.11 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $1.28 Million - $1.55 Million	19,300 Added 229.76%	27,700 $2.21 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $9.04 Million - $10.9 Million	-148,600 Reduced 94.65%	8,400 $616,000
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $2.51 Million - $2.69 Million	46,800 Added 42.47%	157,000 $8.96 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $5.3 Million - $5.91 Million	110,200	110,200 $5.88 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.2 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.76 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.51 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.09 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account